In vitro and in vivo study of dolichyl phosphate on the efflux activity of P-glycoprotein at the blood-brain barrier

International Journal of Developmental Neuroscience

Volumn 31, Issue 8, 2013, Pages 828-835

  Ji, Bian Sheng ^a   Cen, Juan ^a   Liu, Lu ^a   He, Ling ^b  

^a HENAN UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Blood brain barrier; Dolichyl phosphate; P glycoprotein

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CLAUDIN 5; DOLICHOL PHOSPHATE; FLUORESCEIN SODIUM; GELATINASE A; GELATINASE B; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE 123;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN CORTEX; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT;

ALZHEIMER'S DISEASE; BLOOD-BRAIN BARRIER; DOLICHYL PHOSPHATE; P-GLYCOPROTEIN;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLAUDIN-5; COCULTURE TECHNIQUES; DOLICHOL PHOSPHATES; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; P-GLYCOPROTEIN; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 84887355127     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.10.005     Document Type: Article

References (36)

1. Abuznait A.H., Cain C., Ingram D., Burk D., Kaddoumi A. Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease. J. Pharm. Pharmacol. 2011, 63:1111-1118.
2. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 1999, 39:361-398.
3. Bauer B., Hartz A.M., Miller D.S. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol. Pharmacol. 2007, 71:667-675.
4. Boche D., Zotova E., Weller R.O., Love S., Neal J.W., Pickering R.M., Wilkinson D., Holmes C., Nicoll J.A. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain 2008, 131:3299-3310.
5. Burda P., Aebi M. The dolichol pathway of N-linked glycosylation. Biochim. Biophys. Acta 1999, 1426:239-257.
6. Cecchelli R., Dehouck B., Descamps L., Fenart L., Buee-Scherrer C., Duhem V., Lundquist S., Rentfel M., Torpier G., Dehouck M.P. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 1999, 36:165-178.
7. Cen J., Qi Y., Tao Y.F., Deng Y., Fang W.R., Li Y.M., Zhang L.Y., Huang W.L. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM. Eur. J. Pharmacol. 2010, 647:21-30.
8. Cen J., Liu L., He L., Ji B.S. Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats. J. Pharm. Pharmacol. 2013, 65:665-672.
9. Cirrito J.R., Deane R., Fagan A.M., Spinner M.L., Parsadanian M., Finn M.B., Jiang H., Prio r J.L., Sagare A., Bales K.R., Paul S.M., Zlokovic B.V., Piwnica-Worms D., Holtzman D.M. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J. Clin. Invest. 2005, 115:3285-3290.
10. Dazert P., Suofu Y., Grube M., Popa-Wagner A., Kroemer H.K., Jedlitschky G., Kessler C. Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats. Neuroscience 2006, 142:1071-1079.
11. Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-β peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2009, 8:16-30.
12. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 2002, 295:2264-2267.
13. Edlund C., Söderberg M., Kristensson K., Dallner G. Ubiquinone, dolichol, and cholesterol metabolism in aging and Alzheimer's disease. Biochem. Cell Biol. 1992, 70:422-428.
14. Gaillard P.J., Voorwinden L.H., Nielsen J.L., Ivanov A., Atsumi R., Engman H., Ringbom C., de Boer A.G., Breimer D.D. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 2001, 12:215-222.
15. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2:48-58.
16. Greenberg B.D., Murphy M.F. Toward an integrated discovery and development program in Alzheimer's disease: the amyloid hypothesis. Neurobiol. Aging 1994, 15(Suppl. 2):S105-S109.
17. Hafny B., Chappey O., Piciotti M., Debray M., Boval B., Roux F. Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line. Neurosci. Lett. 1997, 236:107-111.
18. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 1991, 12:383-388.
19. Hartz A.M., Miller D.S., Bauer B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol. Pharmacol. 2010, 77:715-723.
20. Hong H., Lu Y., Ji Z.N., Liu G.Q. Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells. J. Neurochem. 2006, 98:1465-1473.
21. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. (Berl.) 2010, 120:287-296.
22. Jeliazkova-Mecheva V.V., Bobilya D.J. A porcine astrocyte/endothelial cell co-culture model of the blood-brain barrier. Brain Res. Brain Res. Protoc. 2003, 12:91-98.
23. Kuhnke D., Jedlitschky G., Grube M., Krohn M., Jucker M., Mosyagin I., Cascorbi I., Walker L.C., Kroemer H.K., Warzok R.W., Vogelgesang S. MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides - implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol. 2007, 17:347-353.
24. Megard I., Garrigues A., Orlowski S., Jorajuria S., Clayette P., Ezan E., Mabondzo A. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation. Brain Res. 2002, 927(February):153-167.
25. Orgogozo J.M., Gilman S., Dartigues J.F., Laurent B., Puel M., Kirby L.C., Jouanny P., Dubois B., Eisner L., Flitman S., Michel B.F., Boada M., Frank A., Hock C. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003, 61:46-54.
26. Raina P., Santaguida P., Ismaila A., Patterson C., Cowan D., Levine M., Booker L., Oremus M. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann. Intern. Med. 2008, 148:379-397.
27. Rutten M.J.R., Hoover T., Karnovsky M.J. Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures. Brain Res. 1987, 425:301-310.
28. Söderberg M., Edlund C., Alafuzoff I., Kristensson K., Dallner G. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J. Neurochem. 1992, 59:1646-1653.
29. Schedin S., Pentchev P.G., Brunk U., Dallner G. Changes in the levels of dolichol and dolichyl phosphate in a murine model of Niemann-Pick's type C disease. J. Neurochem. 1995, 65:670-676.
30. Schenk B., Fernandez F., Waechter C.J. The ins(ide) and outs(ide) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum. Glycobiology 2001, 11:61R-70R.
31. Schinkel A.H., Smit J.J., vanTellingen O., Beijnen J.H., Wagenaar E., vanDeemter L., Mol C.A., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994, 77:491-502.
32. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., Zlokovic B.V. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 2000, 106:1489-1499.
33. Sobue K., Yamamoto N., Yoneda K., Hodgson M.E., Yamashiro K., Tsuruoka N., Tsuda T., Katsuya H., Miura Y., Asai K., Kato T. Induction of blood-brain barrier properties in immortalized bovine brain endothelial c-ells by astrocytic factors. Neurosci. Res. 1999, 35:155-164.
34. Thiel C., Schwarz M., Hasilik M., Grieben U., Hanefeld F., Lehle L., von Figura K., Körner C. Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig. Biochem. J. 2002, 367:195-201.
35. Wijesuriya H.C., Bullock J.Y., Faull R.L., Hladky S.B., Barrand M.A. ABC. efflux transporters in brain vasculature of Alzheimer's subjects. Brain Res. 2010, 1358:228-238.
36. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's Neurodegeneration. Trends Neurosci. 2005, 28:202-208.